- Home
- MLCO vs SRRK Comparison
MLCO vs SRRK Comparison
Compare MLCO & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLCO
- SRRK
- Stock Information
- Founded
- MLCO 2004
- SRRK 2012
- Country
- MLCO Hong Kong
- SRRK United States
- Employees
- MLCO N/A
- SRRK N/A
- Industry
- MLCO Hotels/Resorts
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLCO Consumer Discretionary
- SRRK Health Care
- Exchange
- MLCO Nasdaq
- SRRK Nasdaq
- Market Cap
- MLCO 3.7B
- SRRK 3.2B
- IPO Year
- MLCO 2006
- SRRK 2018
- Fundamental
- Price
- MLCO $8.97
- SRRK $38.95
- Analyst Decision
- MLCO Buy
- SRRK Strong Buy
- Analyst Count
- MLCO 5
- SRRK 7
- Target Price
- MLCO $9.08
- SRRK $42.17
- AVG Volume (30 Days)
- MLCO 4.6M
- SRRK 1.2M
- Earning Date
- MLCO 07-31-2025
- SRRK 08-06-2025
- Dividend Yield
- MLCO N/A
- SRRK N/A
- EPS Growth
- MLCO N/A
- SRRK N/A
- EPS
- MLCO 0.14
- SRRK N/A
- Revenue
- MLCO $4,758,114,000.00
- SRRK N/A
- Revenue This Year
- MLCO $9.18
- SRRK N/A
- Revenue Next Year
- MLCO $5.06
- SRRK $1,960.31
- P/E Ratio
- MLCO $62.96
- SRRK N/A
- Revenue Growth
- MLCO 14.07
- SRRK N/A
- 52 Week Low
- MLCO $4.55
- SRRK $6.76
- 52 Week High
- MLCO $9.17
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- MLCO 71.43
- SRRK 55.72
- Support Level
- MLCO $8.78
- SRRK $36.91
- Resistance Level
- MLCO $9.16
- SRRK $41.33
- Average True Range (ATR)
- MLCO 0.25
- SRRK 1.84
- MACD
- MLCO -0.06
- SRRK -0.12
- Stochastic Oscillator
- MLCO 70.77
- SRRK 51.57
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts and Entertainment Ltd is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao with the rest largely from the Philippines as of 2024.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.